Heimburger Award 2018)

Professor Heimburger Award

Celebrating Science

Professor Dr. Norbert Heimburger, a CSL Behring employee for over three decades, devoted his work to blood coagulation. During that time, he characterized and purified a large number of plasma proteins and was instrumental in making these available to the medical community as therapeutic options. One of his major contributions in this area was the development of virus-safe plasma products based on pasteurization. Due to his determination and his constant interaction with leading hemophilia and coagulation specialists, Behring launched the first effectively virus-inactivated FVIII concentrate in 1981. Honored with the Order of Merit of the Federal Republic of Germany in 1991, Professor Dr. Heimburger retired in 1991 but was still very much involved with CSL Behring as a Scientific Advisor until he passed away in September 2006.

Professor Heimburger

Prof. Heimburger Award

CSL Behring named this grant CSL Behring - Prof. Heimburger Award to honor Professor Dr. Heimburger.

Read our latest newsletter

Global Research Grant

Researcher testing sample

CSL Behring is committed to supporting progress in the area of coagulation in the long term. Based on recent publications and feedback from the medical community, allowing the next generation of coagulation specialists to medically and scientifically establish themselves, it is important to ensure continued progress in this therapeutic area. CSL Behring will fund the ninth cycle of a global grant program to support the above objective.

Grant Details and Eligibility

CSL Behring will set five global start-up grants of €20,000 each.

The grants are reserved for researchers who hold a medical degree. Applicants with less than five years of faculty experience in hemostasis will be preferred.

No matching funding is a prerequisite for this grant. The grants will be available for clinical and/or preclinical research in the area of coagulation.

Current Grant Cycle
Application (PDF)
Application Procedure For inquiries regarding application, policy and procedures information, please contact us. Applications consisting of application form, short CV and research proposal (one-pager) must be postmarked by November 17, 2019 to be considered for the next cycle.

CSL Behring GmbH
Att. Dieter Pluennecke
Commercial Development Coagulation
Emil-von-Behring-Strasse 76
35041 Marburg
T: +49 6421 394191
e-mail: heimburger.award@cslbehring.com

Applications should be submitted in English to the address above.

Prior Years Winners

  • Maaike Blaauwgeers, M.D., University Medical Center Utrecht (Netherlands)
  • Beth Warren, M.D., University of Colorado Anschutz Medial Campus (USA)
  • Saravanan Subramaniam, M.D., McAllister Heart Institute, UNC (USA)
  • Sandra Le Quellec, M.D., Hôpital Cardiologique Louis Pradel, France (France)
  • Elise Huisman, M.D., Erasmus MC Sophia (Netherlands)
  • Antonino Cannavò, M.D., Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico (Italy)
  • Christopher Ng, M.D., University of Colorado Denver, University of Colorado Hemophilia and Thrombosis Center (U.S.)
  • Alessandro Casini, M.D., University Hospitals of Geneva, Unit of Angiology and Haemostasis (Switzerland)
  • Johan Boender, M.D., Erasmus University Medical Center Rotterdam (Netherlands)
  • Michiel Coppens, M.D., Academisch Medisch Centrum (Netherlands)
  • Ashwini Bennett, M.D., Hematology Department, Monash Health (Australia)
  • Bryce Andrew Kerlin, M.D., Associate Professor of Pediatrics, The Ohio State University College of Medicine (U.S.)
  • Jenny Klintman, M.D., Skane University Hospital, Clinical Collaboration Research Unit Lund University (Sweden)
  • Tesse Leunissen, M.D., University Medical Centre Utrecht (Netherlands)
  • Michelle Sonneveld, M.D., Erasmus University Medical Center (Netherlands)
  • Satoshi Nishimura, M.D., PhD, Jichi Medical University, Center for Molecular Medicine, (Japan)
  • Dominic Pepperell, M.D., Royal North Shore Hospital and Sydney University, (Australia)
  • Axel Schlagenhauf, M.D., Department of General Pediatrics and Adolescent Medicine, Medical University of Graz (Austria)
  • Marleen Straat, M.D., Academic Medical Center Amsterdam (Netherlands)
  • Alice van Velzen, M.D., Emma Children’s Hospital, Academic Medical Center (Netherlands)
  • Marije Baaij, M.D., University Medical Center Utrecht (Netherlands)
  • Brain Branchford, M.D., University of Colorado School of Medicine, Children‘s Hospital Colorado (U.S.)
  • James David McFadyen, M.D., Australian Centre for Blood Diseases, Alfred Hospital and Monash University (Australia)
  • Karin Petronella Maria van Galen, M.D., University Medical Center Utrecht Van Creveldkliniek (Netherlands)
  • Heiko Ruhl, M.D., Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn (Germany)
More Information 

Grant statutes are available by downloading Research Grant Statutes.

Note: To view this document, you must have Adobe Acrobat Reader installed. Reader is available as a free download from Adobe Systems Inc.

R&D Capabilities

See what we're working on.

Learn More

Join us and make history with the brightest, most passionate people from every discipline.

Learn More
Our Products

Discover CSL Behring's therapies.

Learn More